Latest News
Lilly Surges on EU Leukemia Drug Approval; Pre-Market Nears Analyst Target
Eli Lilly shares jumped 7.13% to a record $1,208.12 Friday, adding $75.7B in market cap after EU regulators recommended Jaypirca for chronic lymphocytic leukemia.
Apple Stock Steady Amid $100 Billion Buyback and DRAM Policy Risks
Apple shares held steady near $284 after a 3.14% Friday surge, as a $100 billion buyback plan offsets rising DRAM costs and policy risks from a potential CXMT deal.
South Korea's $518B Chip Plan Fails to Impress Investors
South Korea's revised 800 trillion won ($518.3B) chip plan, down 60% from earlier estimates, sent Samsung down 4.86% and SK Hynix down 1.68% as investors focused on capex load.
Hormuz Tanker Imbalance Sparks Oil Glut Fears as Brent Edges Higher
Brent crude rose 0.6% to $72.44 as U.S.-Iran strikes disrupted Hormuz shipping, but a growing tanker imbalance—four ships leaving for every one arriving—raises glut risks and threatens supply restart.
SpaceX Launches SiriusXM Satellite, Shifting Focus to Service Timeline
SpaceX launched SiriusXM's SXM-11 satellite, eliminating launch risk. The market's attention now turns to how quickly the satellite begins service, with the 74-day SXM-10 benchmark in focus.
NASA's $30M Swift Rescue Mission Could Pave Way for Satellite Servicing
NASA's $30 million contract with Katalyst Space aims to boost the Swift satellite, testing a scalable rescue model that could save billions in replacement costs.
NASA Awards $30M Satellite Boost Contract; SpaceX Launches Sirius XM Satellite
NASA contracts Katalyst Space for a satellite boost mission, SpaceX launches SXM-11 for Sirius XM, oil prices rise on Hormuz tanker imbalances, and Lazard offers a high dividend yield amid financial concerns.